Cancer is a major health problem that has increased dramatically over the past two decades. According to the American Cancer Society, approximately 1,638,910 people are diagnosed with cancer in the United States each year; that's about 187 people per minute. This disease is ranked as the second most common cause of death in America. Since cancer is so common today, an effective and relatively quick treatment plan is needed to cure cancer victims without causing them further harm. In-depth research and analysis are key to determining the best treatment method. Cancer can be fatal, but recent advances and a better understanding of the disease have produced great results in overcoming the disease. Aside from patients feeling overwhelmed by the cancer diagnosis, it can be extremely difficult and stressful to make a decision like this that will ultimately lead to life or death. Today the best treatment plan for cancer patients is most likely to combine CAM therapies and medications to reduce the amount of side effects while reducing the size of the tumor and inhibiting any further growth, thus curing the patient. There are several forms of cancer which make it more difficult for the doctor and patient to choose a treatment plan. The two most common types of cancer are breast and colon cancer. It is already estimated that by the end of this year, over 300,000 people will be diagnosed specifically with this type of cancer (ACS, 2012). This number needs to be lowered, but before this can happen an effective and reliable treatment plan must be established. This plan will not only help current and future patients beat cancer, it will provide valuable information about the disease, and doctors and scientists will be able to... half of paper... 207-214.Patyar, S., Joshi, R., Prasad , D., Prakash, A., Medhi, B., & Das, B. (2010). Bacteria in cancer therapy: a new experimental strategy. Journal of Biomedical Science, 17. doi:10.1186/1423-0127-17-21Prica, A., Chan, K., and Cheung, M. (2012). Combined modality therapy versus chemotherapy as an induction regimen for primary central nervous system lymphoma: a decision analysis. British Journal Of Haematology, 158, 600-607. Urruticoechea, A., Alemany, R., Balart, J., Villanueva, A., Vinals, F., Capella, G. (2010). Recent advances in cancer therapy: an overview. Current Pharmaceutical Design, 16, 3-10.Veracity, D. (2005). Cancer Killer Treatment: How Toxic Chemotherapy Kills Both Cancer Cells and Cancer Patients. Natural News: Natural Health News and Scientific Breakthroughs, 5. Retrieved from http://www.naturalnews.com/012727_chemotherapy_cancer_treatments.html